Suppr超能文献

相似文献

1
How to design effective vaccines: lessons from an old success story.
Expert Rev Vaccines. 2009 May;8(5):543-6. doi: 10.1586/erv.09.26.
2
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.
J Exp Med. 2008 Dec 22;205(13):3119-31. doi: 10.1084/jem.20082292. Epub 2008 Dec 1.
3
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.
J Clin Invest. 2014 Jul;124(7):3147-58. doi: 10.1172/JCI75429. Epub 2014 Jun 9.
4
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.
Emerg Microbes Infect. 2021 Dec;10(1):2279-2290. doi: 10.1080/22221751.2021.2008772.
5
The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.
Expert Rev Vaccines. 2018 Jan;17(1):79-90. doi: 10.1080/14760584.2018.1406800. Epub 2017 Nov 27.
8
Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
J Gen Virol. 2015 Apr;96(Pt 4):804-814. doi: 10.1099/jgv.0.000026. Epub 2014 Dec 16.
10
Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.
Nat Rev Immunol. 2009 Oct;9(10):741-7. doi: 10.1038/nri2629. Epub 2009 Sep 18.

引用本文的文献

1
The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing.
Life Sci. 2021 Jun 1;274:119289. doi: 10.1016/j.lfs.2021.119289. Epub 2021 Mar 4.
2
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
J Control Release. 2020 Dec 10;328:112-126. doi: 10.1016/j.jconrel.2020.08.060. Epub 2020 Aug 31.
3
Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases.
Yonsei Med J. 2018 Mar;59(2):176-186. doi: 10.3349/ymj.2018.59.2.176.
6
Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.
AAPS J. 2014 Nov;16(6):1185-93. doi: 10.1208/s12248-014-9654-z. Epub 2014 Sep 6.

本文引用的文献

1
The inflammasomes: guardians of the body.
Annu Rev Immunol. 2009;27:229-65. doi: 10.1146/annurev.immunol.021908.132715.
2
Rotaviruses and rotavirus vaccines.
Br Med Bull. 2009;90:37-51. doi: 10.1093/bmb/ldp009. Epub 2009 Feb 20.
3
Correlates of protection: novel generations of influenza vaccines.
Vaccine. 2008 Sep 12;26 Suppl 4:D41-4. doi: 10.1016/j.vaccine.2008.07.043.
4
The use of genomics in microbial vaccine development.
Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15.
5
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.
J Exp Med. 2008 Dec 22;205(13):3119-31. doi: 10.1084/jem.20082292. Epub 2008 Dec 1.
6
[New vaccination strategies].
Bull Acad Natl Med. 2008 Mar;192(3):511-8; discussion 518-9.
7
Vaccines: correlates of vaccine-induced immunity.
Clin Infect Dis. 2008 Aug 1;47(3):401-9. doi: 10.1086/589862.
8
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
J Infect Dis. 2008 Apr 1;197(7):944-9. doi: 10.1086/529043.
9
Correlates of protective immunity in poxvirus infection: where does antibody stand?
Immunol Cell Biol. 2008 Jan;86(1):80-6. doi: 10.1038/sj.icb.7100118. Epub 2007 Oct 9.
10
A framework for assessing immunological correlates of protection in vaccine trials.
J Infect Dis. 2007 Nov 1;196(9):1304-12. doi: 10.1086/522428. Epub 2007 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验